The principal response criteria for many clinical trials involve time-to-event variables. Usual methods of analysis for this type of response criterion include product-limit estimators of cumulative survival for the treatment groups, (stratified) logrank tests to compare treatments, and proportional
Assessing treatment–time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials
✍ Scribed by F. Boutitie; F. Gueyffier; S. J. Pocock; J. P. Boissel
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 178 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
✦ Synopsis
Exploration of the variation of treatment effect over time in randomized clinical trials with low event rates is limited by lack of power. A meta-analysis on individual patient data from such trials can partly solve the problem, but brings other computational difficulties. Using an example in hypertension, we describe appropriate methods for graphical description and statistical modelling of treatment-time interactions in large data sets. Also, a method is developed for determining the total number of events required to detect treatment-period interactions of plausible magnitude. We conclude that trialists tend to overinterpret the observed data when looking for potential treatment-time interactions by visual comparisons of survival curves, failing to realize the substantial amounts of data that are needed for their detection and estimation.
📜 SIMILAR VOLUMES
have presented recently an interesting paper on the way to analyse AIDS clinical trials when we have a combined endpoint of infection recurrences and death. They use one of the most famous multivariate generalizations of the proportional hazards model: the model of Wei, Lin and Weissfield (hereafter